SCHEMBL259909

SCHEMBL259909

O=[N+]([O-])c1cccc2cc[nH]c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.54
MAPT P10636 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
APEX1 P27695 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
TSHR P16473 2/20 0.54
KDM4E B2RXH2 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
THRB P10828 1/20 0.54
HPGD P15428 1/20 0.54
NOS3 P29474 1/20 0.54
NOS1 P29475 1/20 0.54
CYP2C19 P33261 1/20 0.54
NOS2 P35228 1/20 0.54
RECQL P46063 1/20 0.54
BLM P54132 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
HSD17B10 Q99714 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethane SCHEMBL28964520 0.89 MAPT (0.45) TDP1MAPTSMN1; SMN2APEX1MEN1
Ethane SCHEMBL28964525 0.87 MAPT (0.44) TDP1MAPTSMN1; SMN2APEX1MEN1
SCHEMBL10463259 0.86 TYMS (0.46) TDP1MAPTSMN1; SMN2APEX1MEN1
SCHEMBL15596391 0.84 ALDH1A1 (0.47) TDP1MAPTSMN1; SMN2APEX1MEN1
Ethoxycarbonyl Group SCHEMBL27476172 0.83 MAPT (0.40) TDP1MAPTSMN1; SMN2APEX1MEN1
SCHEMBL15801718 0.80 ALDH1A1 (0.42) TDP1MAPTSMN1; SMN2APEX1MEN1
SCHEMBL6537493 0.77 ALDH1A1 (0.58) TDP1MAPTSMN1; SMN2APEX1MEN1
SCHEMBL7423121 0.77 ALDH1A1 (0.58) TDP1MAPTSMN1; SMN2APEX1MEN1
SCHEMBL15796857 0.76 ALDH1A1 (0.47) TDP1MAPTMEN1KMT2AALDH1A1
Indole SCHEMBL27976837 0.76 TRPA1 (0.63) TDP1MAPTSMN1; SMN2APEX1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 619 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118580174-A Preparation method of 7-nitroindole 武威广达科技有限公司 2024-09-03 CN claimed
CN-116178469-A Oligonucleotide modified podophyllotoxin derivative and preparation method and application thereof 汤亚杰 2023-05-30 CN claimed
CN-114394963-B Isoxazoline compound, preparation method and application 西北农林科技大学 2023-05-23 CN claimed
CN-110845388-A Method for synthesizing 7-nitroindole 江苏苏利精细化工股份有限公司 2020-02-28 CN claimed
US-9486892-B2 Polishing composition FUJIMI INCORPORATED (JP) 2016-11-08 US claimed
EP-2486115-B1 ELECTRORHEOLOGIC FLUID COMPRISING ORGANIC SUBSTANCES THAT CAN BE DOPED AND USE THEREOF FRAUNHOFER GES FORSCHUNG (DE) 2015-05-20 EP claimed
CN-103059065-B Azo metal complex and preparation method thereof SHANGHAI TOYOU DIGITAL TECH CO LTD 2015-04-22 CN claimed
CN-103059598-B Azo blue-ray optical storage dye and preparation method thereof SHANGHAI TOYOU DIGITAL TECH CO LTD 2014-04-02 CN claimed
CN-103059065-A Azo metal complex and preparation method thereof SHANGHAI TOYOU DIGITAL TECH CO LTD 2013-04-24 CN claimed
CN-103059598-A Azo blue-ray optical storage dye and preparation method thereof SHANGHAI TOYOU DIGITAL TECH CO LTD 2013-04-24 CN claimed
EP-1327632-B1 METHOD FOR PRODUCING TRIMER OF INDOLE DERIVATIVE, AND TRIMER OF INDOLE DERIVATIVE AND LAMINATED STRUCTURE THEREOF MITSUBISHI RAYON CO (JP) 2008-12-03 EP claimed
EP-1077699-A1 AMIDE THERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 2001-02-28 EP claimed
WO-1999059582-A1 AMIDE THERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 1999-11-25 WO claimed
US-12630539-B2 Amide compound, pharmaceutical composition and use thereof ARTIVILA (SHENZHEN) INNOVATION CENTER, LTD. (CN) 2026-05-19 US disclosed
CN-116874548-B MDM2 double-site inhibitor and application thereof in antitumor activity 中国医学科学院药用植物研究所 2026-05-15 CN disclosed
US-20260125423-A1 PEPTIDES FOR INCRETIN SYNTHESIS LILLY CO ELI (US) 2026-05-07 US disclosed
US-4506078-A 7-AMINOINDOLE PHOTOGRAPHIC DYES HOFFMANN-LA ROCHE INC. (US) 1985-03-19 US disclosed
US-4506078-A 7-AMINOINDOLE PHOTOGRAPHIC DYES HOFFMANN-LA ROCHE INC. (US) 1985-03-19 US disclosed
US-3983137-A Process for preparing 3-(indol-3-yl)-dehydronaphthalide hydrochlorides POLAROID CORPORATION (US) 1976-09-28 US disclosed
US-3933854-A CHEMICAL INTERMEDIATES FOR INDICATOR DYES POLAROID CORPORATION (US) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630539-B2 Amide compound, pharmaceutical composition and use thereof JAK2, JAK1, JAK3 TDP1 4239/4885MAPT 4013/4885SMN1; SMN2 3540/4885
US-20260125423-A1 PEPTIDES FOR INCRETIN SYNTHESIS IAPP, GLP1R, VIP TDP1 2549/4885MAPT 1173/4885SMN1; SMN2 1166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.